71 filings
8-K
SBFM
Sunshine Biopharma Inc
8 May 24
Changes in Registrant's Certifying Accountant
4:21pm
8-K
SBFM
Sunshine Biopharma Inc
6 May 24
Changes in Registrant's Certifying Accountant
12:14pm
8-K
SBFM
Sunshine Biopharma Inc
23 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
SBFM
Sunshine Biopharma Inc
1 Apr 24
Sales Grew at an Average Rate of 14% Per Quarter During the Year
2:26pm
8-K
SBFM
Sunshine Biopharma Inc
6 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
8a4i0xngw9iym56
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:19pm
8-K
x25f1mgufj7zu6mg8w1e
16 Feb 24
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
fvizh0t
15 Feb 24
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
11:39am
8-K
w3by1atx3tjty2ykv
12 Feb 24
Entry into a Material Definitive Agreement
9:04am
8-K
4cfl9x8vzdz w06
30 Jan 24
Departure of Directors or Certain Officers
12:38pm
8-K
5blpjejk
7 Dec 23
Submission of Matters to a Vote of Security Holders
4:59pm
8-K
k9qjw
13 Nov 23
Revenues Up Significantly Over Last Year Due to a Key Acquisition
9:00am
8-K
nn5k5
2 Nov 23
Termination of a Material Definitive Agreement
12:18pm
8-K
zn5e d7ejmcnacp
20 Oct 23
Entry into a Material Definitive Agreement
1:06pm
8-K
cfok9q68gczlqgu29
13 Oct 23
Submission of Matters to a Vote of Security Holders
10:44am
8-K
tl8i02mtj6tkn
21 Sep 23
Sunshine Biopharma Receives 180-DAY Extension to Achieve Nasdaq Minimum Bid Compliance
9:08pm
8-K
zu068lc7z m6
11 Aug 23
Results of Operations and Financial Condition
9:00am
8-K
1c6ac4cv5fxx2
16 May 23
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
4:05pm
8-K
plohnvntjf927zh2vc
11 May 23
Results of Operations and Financial Condition
4:59pm
8-K
lvr6hnbr4fj0e
19 Apr 23
Amendments to Articles of Incorporation or Bylaws
8:00am